Blastocystis hominis: evidence for caspase-3-like activity in cells undergoing programmed cell death

Parasitol Res. 2001 Jul;87(7):559-65. doi: 10.1007/s004360100427.

Abstract

We have shown previously that the human intestinal protozoan, Blastocystis hominis, undergoes apoptosis-like programmed cell death (PCD) when exposed to a cytotoxic monoclonal antibody (mAb), 1D5. In the present study, ELISA and immunoblot assays employing chicken anti-CPP32 antibody suggest that caspase-3-like antigens exist in B. hominis. Using colorimetric and flow cytometric assays for caspase-3 activity, we also observed an increase in activity between 1 h and 6 h after exposure to mAb 1D5, with greatest activity at 6 h. These findings suggest that caspase-3-like proteases play an important role in B. hominis undergoing PCD, similar to the phenomenon in higher eukaryotic organisms.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Protozoan / pharmacology
  • Antigens, Protozoan / immunology
  • Apoptosis*
  • Blastocystis hominis / cytology
  • Blastocystis hominis / drug effects
  • Blastocystis hominis / enzymology*
  • Blotting, Western
  • Caspase 3
  • Caspases / analysis
  • Caspases / metabolism*
  • DNA, Protozoan / analysis
  • Electrophoresis, Polyacrylamide Gel
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • Humans
  • Immunoblotting
  • Ploidies

Substances

  • Antibodies, Monoclonal
  • Antibodies, Protozoan
  • Antigens, Protozoan
  • DNA, Protozoan
  • CASP3 protein, human
  • Caspase 3
  • Caspases